Chemical
Browse
Active Pharmaceutical Ingredients
Bioactive chemicals
Agrochemicals
Search
Chemical Structure
Explore
Chemical Similarity
Transformation
Browse
Prodrugs
Drug Metabolites
Metabolite Datasets
Biochemical Action
Browse
Target Level (ChEMBL)
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Mechanism of action
Search
Mechanism of action
BLAST against human drug target
BLAST against selected species (UniProt)
Exposure
Browse
Monitoring data
Downloads
Web services
Bulk downloads
About
About EcoDrug+
Citing
Data Sources
Contact Us
Versions and log file
Display Options:
Molecule Type
Mechanism of Action
Route of Adminstration
Status
Therapeutic Indication
Number of compounds:
7959
NEBIVOLOL HYDROCHLORIDE
(2007)
Small molecule
Beta-1 adrenergic receptor antagonist
ORAL
Approved
Hypertension; Stroke
NEBIVOLOL HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
2007
UNII:
JGS34J7L9I
Molecule Type:
Small molecule
Molecular Formula:
C22H26ClF2NO4
Molecular Weight:
441.9
AlogP:
2.36
PSA:
70.95
HBD:
3.0
HBA:
#RotB:
6.0
Source:
LEVOCETIRIZINE DIHYDROCHLORIDE
(2007)
Small molecule
Histamine H1 receptor antagonist
ORAL
Approved
Conjunctivitis, Allergic; Pruritus; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal; Skin Manifestations; Urticaria
LEVOCETIRIZINE DIHYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
2007
UNII:
SOD6A38AGA
Molecule Type:
Small molecule
Molecular Formula:
C21H27Cl3N2O3
Molecular Weight:
461.82
AlogP:
3.15
PSA:
53.01
HBD:
1.0
HBA:
#RotB:
8.0
Source:
LAPATINIB DITOSYLATE
(2007)
Small molecule
Epidermal growth factor receptor erbB1 inhibitor
ORAL
Approved
Breast Neoplasms
LAPATINIB DITOSYLATE
×
Maximum Phase:
4
First Approval:
2007
UNII:
G873GX646R
Molecule Type:
Small molecule
Molecular Formula:
C43H44ClFN4O11S3
Molecular Weight:
943.49
AlogP:
6.14
PSA:
106.35
HBD:
2.0
HBA:
#RotB:
11.0
Source:
DORIPENEM
(2007)
Small molecule
Bacterial penicillin-binding protein inhibitor
INTRAVENOUS
Approved
Bacterial Infections; Intraabdominal Infections; Pyelonephritis; Urinary Tract Infections
DORIPENEM
×
Maximum Phase:
4
First Approval:
2007
UNII:
BHV525JOBH
Molecule Type:
Small molecule
Molecular Formula:
C15H24N4O6S2
Molecular Weight:
420.51
AlogP:
-1.6
PSA:
162.06
HBD:
5.0
HBA:
#RotB:
7.0
Source:
LEVOCETIRIZINE
(2007)
Small molecule
Unknown
Unknown
Approved
Hypersensitivity
LEVOCETIRIZINE
×
Maximum Phase:
4
First Approval:
2007
UNII:
6U5EA9RT2O
Molecule Type:
Small molecule
Molecular Formula:
C21H25ClN2O3
Molecular Weight:
388.9
AlogP:
3.15
PSA:
53.01
HBD:
1.0
HBA:
#RotB:
8.0
Source:
TEMSIROLIMUS
(2007)
Small molecule
FK506-binding protein 1A inhibitor
INTRAVENOUS
Approved
Carcinoma, Renal Cell; Neoplasms
TEMSIROLIMUS
×
Maximum Phase:
4
First Approval:
2007
UNII:
624KN6GM2T
Molecule Type:
Small molecule
Molecular Formula:
C56H87NO16
Molecular Weight:
1030.3
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
DICLOFENAC EPOLAMINE
(2007)
Small molecule
Cyclooxygenase inhibitor
TOPICAL
Approved
Acute Pain
DICLOFENAC EPOLAMINE
×
Maximum Phase:
4
First Approval:
2007
UNII:
X5F8EKL9ZG
Molecule Type:
Small molecule
Molecular Formula:
C20H24Cl2N2O3
Molecular Weight:
411.33
AlogP:
4.36
PSA:
49.33
HBD:
2.0
HBA:
#RotB:
4.0
Source:
SAPROPTERIN
(2007)
Small molecule
Unknown
Unknown
Approved
Unknown
SAPROPTERIN
×
Maximum Phase:
4
First Approval:
2007
UNII:
EGX657432I
Molecule Type:
Small molecule
Molecular Formula:
C9H15N5O3
Molecular Weight:
241.25
AlogP:
-1.29
PSA:
136.55
HBD:
6.0
HBA:
#RotB:
2.0
Source:
AMMONIA N 13
(2007)
Small molecule
Diagnostic agent
Unknown
Approved
Coronary Artery Disease
AMMONIA N 13
×
Maximum Phase:
4
First Approval:
2007
UNII:
9OQO0E343Z
Molecule Type:
Small molecule
Molecular Formula:
H3N
Molecular Weight:
16.03
AlogP:
0.16
PSA:
35.0
HBD:
1.0
HBA:
#RotB:
0.0
Source:
ROTIGOTINE
(2007)
Small molecule
D2-like dopamine receptor agonist
TRANSDERMAL
Approved
Parkinson Disease; Restless Legs Syndrome
ROTIGOTINE
×
Maximum Phase:
4
First Approval:
2007
UNII:
87T4T8BO2E
Molecule Type:
Small molecule
Molecular Formula:
C19H25NOS
Molecular Weight:
315.48
AlogP:
4.27
PSA:
23.47
HBD:
1.0
HBA:
#RotB:
6.0
Source:
TETRABENAZINE
(2008)
Small molecule
Synaptic vesicular amine transporter inhibitor
ORAL
Approved
Huntington Disease
TETRABENAZINE
×
Maximum Phase:
4
First Approval:
2008
UNII:
Z9O08YRN8O
Molecule Type:
Small molecule
Molecular Formula:
C19H27NO3
Molecular Weight:
317.43
AlogP:
3.24
PSA:
38.77
HBD:
0.0
HBA:
#RotB:
4.0
Source:
ERLOSAMIDE
(2008)
Small molecule
Sodium channel alpha subunit blocker
Unknown
Approved
Epilepsy; Seizures
ERLOSAMIDE
×
Maximum Phase:
4
First Approval:
2008
UNII:
563KS2PQY5
Molecule Type:
Small molecule
Molecular Formula:
C13H18N2O3
Molecular Weight:
250.3
AlogP:
0.45
PSA:
67.43
HBD:
2.0
HBA:
#RotB:
6.0
Source:
IOBENGUANE SULFATE I 123
(2008)
Small molecule
Unknown
Unknown
Approved
Unknown
IOBENGUANE SULFATE I 123
×
Maximum Phase:
4
First Approval:
2008
UNII:
23X1185WBO
Molecule Type:
Small molecule
Molecular Formula:
C16H22I2N6O4S
Molecular Weight:
640.27
AlogP:
1.27
PSA:
61.9
HBD:
3.0
HBA:
#RotB:
2.0
Source:
FOSAPREPITANT DIMEGLUMINE
(2008)
Small molecule
Neurokinin 1 receptor antagonist
INJECTION; INTRAVENOUS; UNKNOWN
Approved
Neoplasms; Postoperative Nausea and Vomiting
FOSAPREPITANT DIMEGLUMINE
×
Maximum Phase:
4
First Approval:
2008
UNII:
D35FM8T64X
Molecule Type:
Small molecule
Molecular Formula:
C37H56F7N6O16P
Molecular Weight:
1004.84
AlogP:
4.37
PSA:
129.91
HBD:
3.0
HBA:
#RotB:
7.0
Source:
OXIGLUTATIONE
(2008)
Small molecule
Glutathione reductase
Unknown
Approved
Unknown
OXIGLUTATIONE
×
Maximum Phase:
4
First Approval:
2008
UNII:
ULW86O013H
Molecule Type:
Small molecule
Molecular Formula:
C20H32N6O12S2
Molecular Weight:
612.64
AlogP:
-3.88
PSA:
317.64
HBD:
10.0
HBA:
#RotB:
21.0
Source:
GADOXETATE DISODIUM
(2008)
Small molecule
Unknown
INTRAVENOUS
Approved
Unknown
GADOXETATE DISODIUM
×
Maximum Phase:
4
First Approval:
2008
UNII:
HOY74VZE0M
Molecule Type:
Small molecule
Molecular Formula:
C23H29GdN3NaO10
Molecular Weight:
687.74
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
CHOLINE FENOFIBRATE
(2008)
Small molecule
Peroxisome proliferator-activated receptor alpha agonist
ORAL
Approved
Cardiovascular Diseases
CHOLINE FENOFIBRATE
×
Maximum Phase:
4
First Approval:
2008
UNII:
4BMH7IZT98
Molecule Type:
Small molecule
Molecular Formula:
C22H28ClNO5
Molecular Weight:
421.92
AlogP:
3.81
PSA:
63.6
HBD:
1.0
HBA:
#RotB:
5.0
Source:
FENOFIBRIC ACID
(2008)
Small molecule
Peroxisome proliferator-activated receptor alpha agonist
ORAL
Approved
Diabetes Mellitus, Type 2; Hypercholesterolemia
FENOFIBRIC ACID
×
Maximum Phase:
4
First Approval:
2008
UNII:
BGF9MN2HU1
Molecule Type:
Small molecule
Molecular Formula:
C17H15ClO4
Molecular Weight:
318.76
AlogP:
3.81
PSA:
63.6
HBD:
1.0
HBA:
#RotB:
5.0
Source:
ELTROMBOPAG OLAMINE
(2008)
Small molecule
Thrombopoietin receptor agonist
ORAL
Approved
Anemia, Aplastic; Hepatitis C, Chronic; Purpura, Thrombocytopenic, Idiopathic; Thrombocytopenia
ELTROMBOPAG OLAMINE
×
Maximum Phase:
4
First Approval:
2008
UNII:
4U07F515LG
Molecule Type:
Small molecule
Molecular Formula:
C29H36N6O6
Molecular Weight:
564.64
AlogP:
4.56
PSA:
114.59
HBD:
3.0
HBA:
#RotB:
5.0
Source:
BUPROPION HYDROBROMIDE
(2008)
Small molecule
Dopamine transporter inhibitor
ORAL
Approved
Depressive Disorder; Depressive Disorder, Major
BUPROPION HYDROBROMIDE
×
Maximum Phase:
4
First Approval:
2008
UNII:
E70G3G5863
Molecule Type:
Small molecule
Molecular Formula:
C13H19BrClNO
Molecular Weight:
320.66
AlogP:
3.3
PSA:
29.1
HBD:
1.0
HBA:
#RotB:
3.0
Source:
METHYL SALICYLATE
(2008)
Small molecule
Unknown
Unknown
Approved
Arthritis; Back Pain; Bursitis; Contusions; Muscle Cramp; Myalgia; Pain; Sprains and Strains; Tendinopathy; Wounds and Injuries
METHYL SALICYLATE
×
Maximum Phase:
4
First Approval:
2008
UNII:
LAV5U5022Y
Molecule Type:
Small molecule
Molecular Formula:
C8H8O3
Molecular Weight:
152.15
AlogP:
1.18
PSA:
46.53
HBD:
1.0
HBA:
#RotB:
1.0
Source:
BENDAMUSTINE
(2008)
Small molecule
Unknown
IV (INFUSION)
Approved
Neoplasms
BENDAMUSTINE
×
Maximum Phase:
4
First Approval:
2008
UNII:
9266D9P3PQ
Molecule Type:
Small molecule
Molecular Formula:
C16H21Cl2N3O2
Molecular Weight:
358.27
AlogP:
3.26
PSA:
58.36
HBD:
1.0
HBA:
#RotB:
9.0
Source:
PLERIXAFOR
(2008)
Small molecule
C-X-C chemokine receptor type 4 partial agonist
SUBCUTANEOUS
Approved
Lymphoma, Non-Hodgkin; Multiple Myeloma; Neoplasms
PLERIXAFOR
×
Maximum Phase:
4
First Approval:
2008
UNII:
S915P5499N
Molecule Type:
Small molecule
Molecular Formula:
C28H54N8
Molecular Weight:
502.8
AlogP:
0.42
PSA:
78.66
HBD:
6.0
HBA:
#RotB:
4.0
Source:
FESOTERODINE
(2008)
Small molecule
Unknown
Unknown
Approved
Polyuria; Urinary Incontinence
FESOTERODINE
×
Maximum Phase:
4
First Approval:
2008
UNII:
621G617227
Molecule Type:
Small molecule
Molecular Formula:
C26H37NO3
Molecular Weight:
411.59
AlogP:
5.38
PSA:
49.77
HBD:
1.0
HBA:
#RotB:
10.0
Source:
SILODOSIN
(2008)
Small molecule
Alpha-1a adrenergic receptor antagonist
ORAL
Approved
Prostatic Hyperplasia
SILODOSIN
×
Maximum Phase:
4
First Approval:
2008
UNII:
CUZ39LUY82
Molecule Type:
Small molecule
Molecular Formula:
C25H32F3N3O4
Molecular Weight:
495.54
AlogP:
3.07
PSA:
97.05
HBD:
3.0
HBA:
#RotB:
13.0
Source:
DESVENLAFAXINE SUCCINATE
(2008)
Small molecule
Norepinephrine transporter inhibitor
ORAL
Approved
Depressive Disorder, Major
DESVENLAFAXINE SUCCINATE
×
Maximum Phase:
4
First Approval:
2008
UNII:
H9E1T0BI90
Molecule Type:
Small molecule
Molecular Formula:
C20H31NO6
Molecular Weight:
381.47
AlogP:
2.73
PSA:
43.7
HBD:
2.0
HBA:
#RotB:
4.0
Source:
GADOFOSVESET TRISODIUM
(2008)
Small molecule
Diagnostic agent
INTRAVENOUS
Approved
Unknown
GADOFOSVESET TRISODIUM
×
Maximum Phase:
4
First Approval:
2008
UNII:
XM33Q67UVH
Molecule Type:
Small molecule
Molecular Formula:
C33H38GdN3Na3O14P
Molecular Weight:
957.87
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
LEVOLEUCOVORIN
(2008)
Small molecule
Unknown
INTRAVENOUS
Approved
Anemia; Colorectal Neoplasms; Osteosarcoma
LEVOLEUCOVORIN
×
Maximum Phase:
4
First Approval:
2008
UNII:
990S25980Y
Molecule Type:
Small molecule
Molecular Formula:
C20H23N7O7
Molecular Weight:
473.45
AlogP:
-0.73
PSA:
219.84
HBD:
7.0
HBA:
#RotB:
10.0
Source:
ETRAVIRINE
(2008)
Small molecule
Human immunodeficiency virus type 1 reverse transcriptase inhibitor
ORAL
Approved
HIV; HIV Infections; Virus Diseases
ETRAVIRINE
×
Maximum Phase:
4
First Approval:
2008
UNII:
0C50HW4FO1
Molecule Type:
Small molecule
Molecular Formula:
C20H15BrN6O
Molecular Weight:
435.29
AlogP:
4.72
PSA:
120.64
HBD:
2.0
HBA:
#RotB:
4.0
Source:
FOSPROPOFOL DISODIUM
(2008)
Small molecule
Unknown
Unknown
Approved
Unknown
FOSPROPOFOL DISODIUM
×
Maximum Phase:
4
First Approval:
2008
UNII:
30868AY0IF
Molecule Type:
Small molecule
Molecular Formula:
C13H19Na2O5P
Molecular Weight:
332.24
AlogP:
3.38
PSA:
75.99
HBD:
2.0
HBA:
#RotB:
6.0
Source:
CLEVIDIPINE
(2008)
Small molecule
Voltage-gated L-type calcium channel blocker
INTRAVENOUS
Approved
Cardiovascular Diseases
CLEVIDIPINE
×
Maximum Phase:
4
First Approval:
2008
UNII:
19O2GP3B7Q
Molecule Type:
Small molecule
Molecular Formula:
C21H23Cl2NO6
Molecular Weight:
456.32
AlogP:
4.25
PSA:
90.93
HBD:
1.0
HBA:
#RotB:
7.0
Source:
DIFLUPREDNATE
(2008)
Small molecule
Glucocorticoid receptor agonist
OPHTHALMIC
Approved
Inflammation; Uveitis, Anterior
DIFLUPREDNATE
×
Maximum Phase:
4
First Approval:
2008
UNII:
S8A06QG2QE
Molecule Type:
Small molecule
Molecular Formula:
C27H34F2O7
Molecular Weight:
508.56
AlogP:
3.52
PSA:
106.97
HBD:
1.0
HBA:
#RotB:
6.0
Source:
REGADENOSON
(2008)
Small molecule
Adenosine A2a receptor agonist
INTRAVENOUS
Approved
Cardiovascular Diseases
REGADENOSON
×
Maximum Phase:
4
First Approval:
2008
UNII:
7AXV542LZ4
Molecule Type:
Small molecule
Molecular Formula:
C15H20N8O6
Molecular Weight:
408.38
AlogP:
-2.43
PSA:
186.46
HBD:
5.0
HBA:
#RotB:
4.0
Source:
GADOFOSVESET
(2008)
Small molecule
Diagnostic agent
Unknown
Approved
Unknown
GADOFOSVESET
×
Maximum Phase:
4
First Approval:
2008
UNII:
E65RW73PHS
Molecule Type:
Small molecule
Molecular Formula:
C33H44GdN3O14P+3
Molecular Weight:
894.95
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
BENDAMUSTINE HYDROCHLORIDE
(2008)
Small molecule
DNA inhibitor
INJECTION; IV (INFUSION)
Approved
Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Non-Hodgkin
BENDAMUSTINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
2008
UNII:
981Y8SX18M
Molecule Type:
Small molecule
Molecular Formula:
C16H22Cl3N3O2
Molecular Weight:
394.73
AlogP:
3.26
PSA:
58.36
HBD:
1.0
HBA:
#RotB:
9.0
Source:
TAPENTADOL HYDROCHLORIDE
(2008)
Small molecule
Mu opioid receptor agonist
ORAL
Approved
Acute Pain; Chronic Pain; Neuralgia; Pain
TAPENTADOL HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
2008
UNII:
71204KII53
Molecule Type:
Small molecule
Molecular Formula:
C14H24ClNO
Molecular Weight:
257.81
AlogP:
3.08
PSA:
23.47
HBD:
1.0
HBA:
#RotB:
5.0
Source:
1
2
…
57
58
59
60
61
62
63
…
221
222
Next »
Download Option
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA